CD44 and cancer: Considering that MDA‐MB‐453 lacks CD44 expression and research indicates that EpCAM+/CD24‒ MDA‐MB‐453 cells possess cancer stem cell characteristics, we used EpCAM and CD24 as markers to identify the proportion of BCSCs in MDA‐MB‐453.37